🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Marc C. Chamberlain

ORCID: 0000-0002-1613-1123

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Phase II trial of blood–brain barrier permeable peptide-paclitaxel conjugate ANG1005 in patients with recurrent high-grade glioma”.

Phase II trial of blood–brain barrier permeable peptide-paclitaxel conjugate ANG1005 in patients with recurrent high-grade glioma

Neuro-Oncology Advances(2024)10.1093/noajnl/vdae186

N/A

0.574DataRank · unranked

17 citations

Andrew Brenner, David Piccioni, Patrick Y Wen, Jan Drappatz, Maciej Mrugala +10 more

Phase 1b/2 study of orally administered pexidartinib in combination with radiation therapy and temozolomide in patients with newly diagnosed glioblastoma

Neuro-Oncology Advances(2024)10.1093/noajnl/vdae202

N/A

0.345DataRank · unranked

9 citations

Adam L. Cohen, Midori Eckenstein, Randy L. Jensen, Lindsay Burt, Karen L. Salzman +18 more

A Bayesian adaptive randomized phase II multicenter trial of bevacizumab with or without vorinostat in adults with recurrent glioblastoma

Neuro-Oncology(2020)10.1093/neuonc/noaa062

N/A

0DataRank · unranked

46 citations

Jing Wu, Ying Yuan, Terri S. Armstrong, Elizabeth Vera, Jimin Wu +18 more